Disparities in Opioid Access for Cancer Pain at End of Life
Black and Hispanic patients nearing the end of life are less likely than White patients to get needed opioid medications for cancer pain.
Black and Hispanic patients nearing the end of life are less likely than White patients to get needed opioid medications for cancer pain.
We have noticed an unusual activity from your IP 199.16.157.180 and blocked access to this
Defects in RNA processing can promote cancer — but the mutated proteins responsible can be hard to target. Fred Hutch Cancer Center and Memorial Sloan…
Researchers uncover lung adenocarcinoma’s early roots, tracing the cancer back to a specific cell type. These insights offer new hope for detection and prevention.
Nature Reviews Cancer – In this Journal Club, Oh and Kim discuss a study demonstrating the mechanisms underlying histological transformation of lung adenocarcinoma to neuroendocrine…
Nature Reviews Cancer – Connie J. Eaves (1944–2024)
Nature Reviews Cancer – In this Review, Zhang and colleagues provide an overview of the molecular characteristics of paediatric cancer and highlight how these malignancies…
Adaptation of transfer learning to relate human single-cell RNA sequencing data to organoid-CAF cocultures facilitates discovery of human pancreatic cancer intercellular interactions and uncovers cross-talk…
Emerging evidence suggests that the consequences of climate change may have an impact on the development of cancer and cancer care.
Kian-Huat Lim, MD, PhD, discusses the role of multidisciplinary collaboration and clinical trials in the treatment of pancreatic cancer.
A phase III trial found that mitoxantrone-based induction resulted in better outcomes vs liposomal daunorubicin–based induction in pediatric patients with acute myeloid leukemia.